nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludrocortisone—Parkinson's disease—Clonazepam—epilepsy syndrome	0.289	0.554	CpDpCtD
Fludrocortisone—NR3C1—epilepsy syndrome	0.276	1	CbGaD
Fludrocortisone—Parkinson's disease—Gabapentin—epilepsy syndrome	0.233	0.446	CpDpCtD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—ATP6AP2—epilepsy syndrome	0.00229	0.0621	CbGpPWpGaD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—BDKRB1—epilepsy syndrome	0.00183	0.0497	CbGpPWpGaD
Fludrocortisone—NR3C2—Preimplantation Embryo—SIX3—epilepsy syndrome	0.00176	0.0476	CbGpPWpGaD
Fludrocortisone—NR3C2—hindbrain—epilepsy syndrome	0.0017	0.102	CbGeAlD
Fludrocortisone—NR3C2—Preimplantation Embryo—FOSB—epilepsy syndrome	0.00161	0.0436	CbGpPWpGaD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—BDKRB2—epilepsy syndrome	0.00127	0.0344	CbGpPWpGaD
Fludrocortisone—NR3C2—brainstem—epilepsy syndrome	0.000977	0.0582	CbGeAlD
Fludrocortisone—NR3C2—forebrain—epilepsy syndrome	0.000942	0.0562	CbGeAlD
Fludrocortisone—NR3C1—hindbrain—epilepsy syndrome	0.000914	0.0545	CbGeAlD
Fludrocortisone—NR3C2—telencephalon—epilepsy syndrome	0.000867	0.0517	CbGeAlD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—SNIP1—epilepsy syndrome	0.000824	0.0223	CbGpPWpGaD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—AGT—epilepsy syndrome	0.000808	0.0219	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—ASCL1—epilepsy syndrome	0.000731	0.0198	CbGpPWpGaD
Fludrocortisone—AR—forebrain—epilepsy syndrome	0.000698	0.0416	CbGeAlD
Fludrocortisone—NR3C2—medulla oblongata—epilepsy syndrome	0.000681	0.0406	CbGeAlD
Fludrocortisone—AR—telencephalon—epilepsy syndrome	0.000642	0.0383	CbGeAlD
Fludrocortisone—AR—Nongenotropic Androgen signaling—GNAO1—epilepsy syndrome	0.000627	0.017	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SNIP1—epilepsy syndrome	0.000625	0.0169	CbGpPWpGaD
Fludrocortisone—NR3C2—midbrain—epilepsy syndrome	0.000622	0.0371	CbGeAlD
Fludrocortisone—NR3C2—spinal cord—epilepsy syndrome	0.000607	0.0362	CbGeAlD
Fludrocortisone—NR3C2—head—epilepsy syndrome	0.00054	0.0322	CbGeAlD
Fludrocortisone—NR3C1—brainstem—epilepsy syndrome	0.000524	0.0312	CbGeAlD
Fludrocortisone—NR3C2—nervous system—epilepsy syndrome	0.000512	0.0305	CbGeAlD
Fludrocortisone—NR3C1—forebrain—epilepsy syndrome	0.000506	0.0302	CbGeAlD
Fludrocortisone—NR3C2—central nervous system—epilepsy syndrome	0.000493	0.0294	CbGeAlD
Fludrocortisone—AR—SIDS Susceptibility Pathways—SNTA1—epilepsy syndrome	0.000488	0.0132	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—FOSB—epilepsy syndrome	0.000487	0.0132	CbGpPWpGaD
Fludrocortisone—NR3C2—cerebellum—epilepsy syndrome	0.000481	0.0287	CbGeAlD
Fludrocortisone—NR3C1—telencephalon—epilepsy syndrome	0.000465	0.0277	CbGeAlD
Fludrocortisone—AR—spinal cord—epilepsy syndrome	0.00045	0.0268	CbGeAlD
Fludrocortisone—NR3C1—Endoderm Differentiation—DUSP5—epilepsy syndrome	0.000413	0.0112	CbGpPWpGaD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—VDR—epilepsy syndrome	0.000411	0.0111	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CACNA1G—epilepsy syndrome	0.000406	0.011	CbGpPWpGaD
Fludrocortisone—AR—head—epilepsy syndrome	0.0004	0.0238	CbGeAlD
Fludrocortisone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR7—epilepsy syndrome	0.000391	0.0106	CbGpPWpGaD
Fludrocortisone—NR3C2—brain—epilepsy syndrome	0.000391	0.0233	CbGeAlD
Fludrocortisone—AR—nervous system—epilepsy syndrome	0.000379	0.0226	CbGeAlD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—SNTA1—epilepsy syndrome	0.00037	0.01	CbGpPWpGaD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—NR3C1—epilepsy syndrome	0.00037	0.01	CbGpPWpGaD
Fludrocortisone—NR3C1—medulla oblongata—epilepsy syndrome	0.000365	0.0218	CbGeAlD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—UBE3A—epilepsy syndrome	0.000365	0.00989	CbGpPWpGaD
Fludrocortisone—AR—central nervous system—epilepsy syndrome	0.000365	0.0218	CbGeAlD
Fludrocortisone—AR—Nongenotropic Androgen signaling—PLCB1—epilepsy syndrome	0.000356	0.00966	CbGpPWpGaD
Fludrocortisone—NR3C1—midbrain—epilepsy syndrome	0.000334	0.0199	CbGeAlD
Fludrocortisone—NR3C1—spinal cord—epilepsy syndrome	0.000326	0.0194	CbGeAlD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—KCNJ11—epilepsy syndrome	0.00032	0.00869	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—TCF4—epilepsy syndrome	0.000306	0.00829	CbGpPWpGaD
Fludrocortisone—AR—Nongenotropic Androgen signaling—CDC42—epilepsy syndrome	0.000303	0.00822	CbGpPWpGaD
Fludrocortisone—AR—brain—epilepsy syndrome	0.00029	0.0173	CbGeAlD
Fludrocortisone—NR3C1—head—epilepsy syndrome	0.000289	0.0173	CbGeAlD
Fludrocortisone—AR—SIDS Susceptibility Pathways—MECP2—epilepsy syndrome	0.00028	0.00759	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—ASCL1—epilepsy syndrome	0.00028	0.00759	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—DUSP4—epilepsy syndrome	0.000275	0.00747	CbGpPWpGaD
Fludrocortisone—NR3C1—nervous system—epilepsy syndrome	0.000274	0.0164	CbGeAlD
Fludrocortisone—AR—Androgen receptor signaling pathway—UBE3A—epilepsy syndrome	0.00027	0.00731	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—FLNA—epilepsy syndrome	0.000266	0.00721	CbGpPWpGaD
Fludrocortisone—NR3C1—central nervous system—epilepsy syndrome	0.000264	0.0158	CbGeAlD
Fludrocortisone—NR3C1—cerebellum—epilepsy syndrome	0.000258	0.0154	CbGeAlD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TCF4—epilepsy syndrome	0.000246	0.00667	CbGpPWpGaD
Fludrocortisone—AR—Nuclear Receptors—VDR—epilepsy syndrome	0.000241	0.00654	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—PTK2B—epilepsy syndrome	0.000232	0.00628	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—DUSP1—epilepsy syndrome	0.000224	0.00606	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—RET—epilepsy syndrome	0.000218	0.0059	CbGpPWpGaD
Fludrocortisone—AR—Nuclear Receptors—NR3C1—epilepsy syndrome	0.000217	0.00588	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—ASCL1—epilepsy syndrome	0.000212	0.00576	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—MECP2—epilepsy syndrome	0.000212	0.00576	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—MAP2—epilepsy syndrome	0.000212	0.00575	CbGpPWpGaD
Fludrocortisone—NR3C1—brain—epilepsy syndrome	0.00021	0.0125	CbGeAlD
Fludrocortisone—NR3C1—AP-1 transcription factor network—JUND—epilepsy syndrome	0.000208	0.00563	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—NTF3—epilepsy syndrome	0.000203	0.00549	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—HES1—epilepsy syndrome	0.000199	0.0054	CbGpPWpGaD
Fludrocortisone—AR—Nongenotropic Androgen signaling—FOS—epilepsy syndrome	0.000195	0.0053	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—GABRA1—epilepsy syndrome	0.000194	0.00526	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—SSTR1—epilepsy syndrome	0.000194	0.00526	CbGpPWpGaD
Fludrocortisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—epilepsy syndrome	0.000193	0.00524	CbGpPWpGaD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—VDR—epilepsy syndrome	0.000191	0.00517	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CAPN1—epilepsy syndrome	0.00019	0.00516	CbGpPWpGaD
Fludrocortisone—AR—Regulation of Androgen receptor activity—SIRT1—epilepsy syndrome	0.000187	0.00508	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—SSTR2—epilepsy syndrome	0.000187	0.00507	CbGpPWpGaD
Fludrocortisone—Spironolactone—SLCO1A2—epilepsy syndrome	0.000186	0.0425	CrCbGaD
Fludrocortisone—Neoplasm—Topiramate—epilepsy syndrome	0.000185	0.00128	CcSEcCtD
Fludrocortisone—Myalgia—Propofol—epilepsy syndrome	0.000184	0.00127	CcSEcCtD
Fludrocortisone—Purpura—Gabapentin—epilepsy syndrome	0.000183	0.00127	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptors—VDR—epilepsy syndrome	0.000183	0.00496	CbGpPWpGaD
Fludrocortisone—Mood swings—Pregabalin—epilepsy syndrome	0.000183	0.00127	CcSEcCtD
Fludrocortisone—Vertigo—Fosphenytoin—epilepsy syndrome	0.000181	0.00125	CcSEcCtD
Fludrocortisone—Pancreatitis—Valproic Acid—epilepsy syndrome	0.000181	0.00125	CcSEcCtD
Fludrocortisone—Convulsion—Levetiracetam—epilepsy syndrome	0.000181	0.00125	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CHRNA7—epilepsy syndrome	0.00018	0.00489	CbGpPWpGaD
Fludrocortisone—Sweating increased—Valproic Acid—epilepsy syndrome	0.000179	0.00124	CcSEcCtD
Fludrocortisone—Myalgia—Levetiracetam—epilepsy syndrome	0.000177	0.00123	CcSEcCtD
Fludrocortisone—Vertigo—Vigabatrin—epilepsy syndrome	0.000176	0.00122	CcSEcCtD
Fludrocortisone—Oedema—Propofol—epilepsy syndrome	0.000176	0.00122	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Propofol—epilepsy syndrome	0.000176	0.00122	CcSEcCtD
Fludrocortisone—Prednisone—SLCO1A2—epilepsy syndrome	0.000175	0.0401	CrCbGaD
Fludrocortisone—Hypersensitivity—Phenobarbital—epilepsy syndrome	0.000175	0.00121	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—MAPK10—epilepsy syndrome	0.000175	0.00475	CbGpPWpGaD
Fludrocortisone—Convulsion—Fosphenytoin—epilepsy syndrome	0.000174	0.00121	CcSEcCtD
Fludrocortisone—Urticaria—Lacosamide—epilepsy syndrome	0.000174	0.00121	CcSEcCtD
Fludrocortisone—Affect lability—Gabapentin—epilepsy syndrome	0.000174	0.00121	CcSEcCtD
Fludrocortisone—Hypertension—Fosphenytoin—epilepsy syndrome	0.000174	0.0012	CcSEcCtD
Fludrocortisone—Vertigo—Diazepam—epilepsy syndrome	0.000173	0.0012	CcSEcCtD
Fludrocortisone—NR3C1—Signaling events mediated by HDAC Class II—MEF2C—epilepsy syndrome	0.000173	0.00469	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Midazolam—epilepsy syndrome	0.000172	0.00119	CcSEcCtD
Fludrocortisone—Hypersensitivity—Rufinamide—epilepsy syndrome	0.000172	0.00119	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—NR3C1—epilepsy syndrome	0.000172	0.00465	CbGpPWpGaD
Fludrocortisone—Myalgia—Fosphenytoin—epilepsy syndrome	0.000171	0.00119	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Topiramate—epilepsy syndrome	0.000171	0.00118	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Propofol—epilepsy syndrome	0.00017	0.00118	CcSEcCtD
Fludrocortisone—Muscular weakness—Pregabalin—epilepsy syndrome	0.00017	0.00118	CcSEcCtD
Fludrocortisone—Convulsion—Vigabatrin—epilepsy syndrome	0.00017	0.00118	CcSEcCtD
Fludrocortisone—Infection—Levetiracetam—epilepsy syndrome	0.000169	0.00117	CcSEcCtD
Fludrocortisone—Urticaria—Clobazam—epilepsy syndrome	0.000169	0.00117	CcSEcCtD
Fludrocortisone—Headache—Trimethadione—epilepsy syndrome	0.000168	0.00117	CcSEcCtD
Fludrocortisone—Abdominal distension—Pregabalin—epilepsy syndrome	0.000168	0.00116	CcSEcCtD
Fludrocortisone—Asthenia—Rufinamide—epilepsy syndrome	0.000167	0.00116	CcSEcCtD
Fludrocortisone—Mood swings—Gabapentin—epilepsy syndrome	0.000167	0.00116	CcSEcCtD
Fludrocortisone—Erythema—Carbamazepine—epilepsy syndrome	0.000167	0.00116	CcSEcCtD
Fludrocortisone—Myalgia—Vigabatrin—epilepsy syndrome	0.000167	0.00116	CcSEcCtD
Fludrocortisone—AR—Regulation of Androgen receptor activity—NR3C1—epilepsy syndrome	0.000166	0.00451	CbGpPWpGaD
Fludrocortisone—Vascular purpura—Topiramate—epilepsy syndrome	0.000166	0.00115	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—RET—epilepsy syndrome	0.000165	0.00448	CbGpPWpGaD
Fludrocortisone—Myalgia—Diazepam—epilepsy syndrome	0.000164	0.00114	CcSEcCtD
Fludrocortisone—Vertigo—Zonisamide—epilepsy syndrome	0.000164	0.00114	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Fosphenytoin—epilepsy syndrome	0.000164	0.00114	CcSEcCtD
Fludrocortisone—Methyltestosterone—SLCO1A2—epilepsy syndrome	0.000164	0.0375	CrCbGaD
Fludrocortisone—NR3C1—Adipogenesis—MIF—epilepsy syndrome	0.000164	0.00445	CbGpPWpGaD
Fludrocortisone—Pancreatitis—Pregabalin—epilepsy syndrome	0.000163	0.00113	CcSEcCtD
Fludrocortisone—Infection—Fosphenytoin—epilepsy syndrome	0.000163	0.00113	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—WARS—epilepsy syndrome	0.000162	0.00439	CbGpPWpGaD
Fludrocortisone—Prednisolone—SLCO1A2—epilepsy syndrome	0.000162	0.037	CrCbGaD
Fludrocortisone—Erythema—Lamotrigine—epilepsy syndrome	0.000162	0.00112	CcSEcCtD
Fludrocortisone—Hypersensitivity—Lacosamide—epilepsy syndrome	0.000161	0.00112	CcSEcCtD
Fludrocortisone—Hypertension—Felbamate—epilepsy syndrome	0.000161	0.00112	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—MAP2—epilepsy syndrome	0.000161	0.00437	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Propofol—epilepsy syndrome	0.00016	0.00111	CcSEcCtD
Fludrocortisone—Oedema—Vigabatrin—epilepsy syndrome	0.00016	0.00111	CcSEcCtD
Fludrocortisone—AR—Notch-mediated HES/HEY network—KDR—epilepsy syndrome	0.000159	0.00432	CbGpPWpGaD
Fludrocortisone—Insomnia—Propofol—epilepsy syndrome	0.000159	0.0011	CcSEcCtD
Fludrocortisone—Myalgia—Felbamate—epilepsy syndrome	0.000159	0.0011	CcSEcCtD
Fludrocortisone—Infection—Vigabatrin—epilepsy syndrome	0.000159	0.0011	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Fosphenytoin—epilepsy syndrome	0.000159	0.0011	CcSEcCtD
Fludrocortisone—Convulsion—Zonisamide—epilepsy syndrome	0.000158	0.0011	CcSEcCtD
Fludrocortisone—Vertigo—Clonazepam—epilepsy syndrome	0.000158	0.0011	CcSEcCtD
Fludrocortisone—Hypertension—Zonisamide—epilepsy syndrome	0.000158	0.00109	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Diazepam—epilepsy syndrome	0.000158	0.00109	CcSEcCtD
Fludrocortisone—Vertigo—Phenytoin—epilepsy syndrome	0.000157	0.00109	CcSEcCtD
Fludrocortisone—Asthenia—Lacosamide—epilepsy syndrome	0.000157	0.00109	CcSEcCtD
Fludrocortisone—Infection—Diazepam—epilepsy syndrome	0.000157	0.00108	CcSEcCtD
Fludrocortisone—Vertigo—Oxcarbazepine—epilepsy syndrome	0.000157	0.00108	CcSEcCtD
Fludrocortisone—Muscular weakness—Gabapentin—epilepsy syndrome	0.000156	0.00108	CcSEcCtD
Fludrocortisone—Myalgia—Zonisamide—epilepsy syndrome	0.000156	0.00108	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Levetiracetam—epilepsy syndrome	0.000155	0.00107	CcSEcCtD
Fludrocortisone—Purpura—Topiramate—epilepsy syndrome	0.000154	0.00107	CcSEcCtD
Fludrocortisone—Insomnia—Levetiracetam—epilepsy syndrome	0.000154	0.00107	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—SLC1A3—epilepsy syndrome	0.000153	0.00416	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—AQP4—epilepsy syndrome	0.000153	0.00416	CbGpPWpGaD
Fludrocortisone—Asthenia—Clobazam—epilepsy syndrome	0.000153	0.00106	CcSEcCtD
Fludrocortisone—Oedema—Felbamate—epilepsy syndrome	0.000153	0.00106	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Felbamate—epilepsy syndrome	0.000153	0.00106	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Diazepam—epilepsy syndrome	0.000152	0.00106	CcSEcCtD
Fludrocortisone—Convulsion—Phenytoin—epilepsy syndrome	0.000152	0.00105	CcSEcCtD
Fludrocortisone—Infection—Felbamate—epilepsy syndrome	0.000152	0.00105	CcSEcCtD
Fludrocortisone—Hypertension—Phenytoin—epilepsy syndrome	0.000151	0.00105	CcSEcCtD
Fludrocortisone—Convulsion—Oxcarbazepine—epilepsy syndrome	0.000151	0.00105	CcSEcCtD
Fludrocortisone—Urticaria—Acetazolamide—epilepsy syndrome	0.000151	0.00104	CcSEcCtD
Fludrocortisone—Hypertension—Oxcarbazepine—epilepsy syndrome	0.00015	0.00104	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Pregabalin—epilepsy syndrome	0.00015	0.00104	CcSEcCtD
Fludrocortisone—Vertigo—Carbamazepine—epilepsy syndrome	0.00015	0.00104	CcSEcCtD
Fludrocortisone—Myalgia—Clonazepam—epilepsy syndrome	0.00015	0.00104	CcSEcCtD
Fludrocortisone—Pancreatitis—Gabapentin—epilepsy syndrome	0.00015	0.00104	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Fosphenytoin—epilepsy syndrome	0.00015	0.00104	CcSEcCtD
Fludrocortisone—Oedema—Zonisamide—epilepsy syndrome	0.000149	0.00103	CcSEcCtD
Fludrocortisone—Myalgia—Phenytoin—epilepsy syndrome	0.000149	0.00103	CcSEcCtD
Fludrocortisone—Headache—Phenobarbital—epilepsy syndrome	0.000149	0.00103	CcSEcCtD
Fludrocortisone—Sweating increased—Gabapentin—epilepsy syndrome	0.000149	0.00103	CcSEcCtD
Fludrocortisone—Insomnia—Fosphenytoin—epilepsy syndrome	0.000149	0.00103	CcSEcCtD
Fludrocortisone—Infection—Zonisamide—epilepsy syndrome	0.000148	0.00103	CcSEcCtD
Fludrocortisone—Myalgia—Oxcarbazepine—epilepsy syndrome	0.000148	0.00103	CcSEcCtD
Fludrocortisone—Haemoglobin—Valproic Acid—epilepsy syndrome	0.000148	0.00103	CcSEcCtD
Fludrocortisone—AR—FOXA1 transcription factor network—FOS—epilepsy syndrome	0.000148	0.004	CbGpPWpGaD
Fludrocortisone—Haemorrhage—Valproic Acid—epilepsy syndrome	0.000147	0.00102	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Felbamate—epilepsy syndrome	0.000147	0.00102	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—SSTR1—epilepsy syndrome	0.000147	0.00399	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—GABRA1—epilepsy syndrome	0.000147	0.00399	CbGpPWpGaD
Fludrocortisone—Affect lability—Topiramate—epilepsy syndrome	0.000146	0.00101	CcSEcCtD
Fludrocortisone—Headache—Rufinamide—epilepsy syndrome	0.000146	0.00101	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Vigabatrin—epilepsy syndrome	0.000146	0.00101	CcSEcCtD
Fludrocortisone—Vertigo—Lamotrigine—epilepsy syndrome	0.000145	0.00101	CcSEcCtD
Fludrocortisone—Convulsion—Carbamazepine—epilepsy syndrome	0.000145	0.001	CcSEcCtD
Fludrocortisone—Insomnia—Vigabatrin—epilepsy syndrome	0.000145	0.001	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—VDR—epilepsy syndrome	0.000145	0.00392	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Zonisamide—epilepsy syndrome	0.000144	0.001	CcSEcCtD
Fludrocortisone—Hypertension—Carbamazepine—epilepsy syndrome	0.000144	0.001	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CHRM2—epilepsy syndrome	0.000144	0.00391	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Clonazepam—epilepsy syndrome	0.000144	0.000997	CcSEcCtD
Fludrocortisone—Oedema—Clonazepam—epilepsy syndrome	0.000144	0.000997	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Diazepam—epilepsy syndrome	0.000144	0.000995	CcSEcCtD
Fludrocortisone—Infection—Clonazepam—epilepsy syndrome	0.000143	0.00099	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Phenytoin—epilepsy syndrome	0.000143	0.00099	CcSEcCtD
Fludrocortisone—Insomnia—Diazepam—epilepsy syndrome	0.000143	0.000988	CcSEcCtD
Fludrocortisone—Myalgia—Carbamazepine—epilepsy syndrome	0.000142	0.000986	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—SIRT1—epilepsy syndrome	0.000142	0.00386	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Oxcarbazepine—epilepsy syndrome	0.000142	0.000985	CcSEcCtD
Fludrocortisone—Infection—Phenytoin—epilepsy syndrome	0.000142	0.000984	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—SSTR2—epilepsy syndrome	0.000142	0.00384	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—JUNB—epilepsy syndrome	0.000141	0.00383	CbGpPWpGaD
Fludrocortisone—Infection—Oxcarbazepine—epilepsy syndrome	0.000141	0.000979	CcSEcCtD
Fludrocortisone—Mood swings—Topiramate—epilepsy syndrome	0.000141	0.000976	CcSEcCtD
Fludrocortisone—NR3C1—Circadian Clock—AVP—epilepsy syndrome	0.000141	0.00382	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TH—epilepsy syndrome	0.00014	0.00381	CbGpPWpGaD
Fludrocortisone—Convulsion—Lamotrigine—epilepsy syndrome	0.00014	0.00097	CcSEcCtD
Fludrocortisone—Urticaria—Propofol—epilepsy syndrome	0.00014	0.000969	CcSEcCtD
Fludrocortisone—Hypertension—Lamotrigine—epilepsy syndrome	0.000139	0.000966	CcSEcCtD
Fludrocortisone—Diflorasone—NR3C1—epilepsy syndrome	0.000139	0.0318	CrCbGaD
Fludrocortisone—Desonide—NR3C1—epilepsy syndrome	0.000139	0.0318	CrCbGaD
Fludrocortisone—Musculoskeletal discomfort—Felbamate—epilepsy syndrome	0.000139	0.000963	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Phenytoin—epilepsy syndrome	0.000138	0.000957	CcSEcCtD
Fludrocortisone—Insomnia—Felbamate—epilepsy syndrome	0.000138	0.000956	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Gabapentin—epilepsy syndrome	0.000138	0.000955	CcSEcCtD
Fludrocortisone—Myalgia—Lamotrigine—epilepsy syndrome	0.000138	0.000953	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Oxcarbazepine—epilepsy syndrome	0.000137	0.000952	CcSEcCtD
Fludrocortisone—Headache—Lacosamide—epilepsy syndrome	0.000137	0.000951	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CHRNA7—epilepsy syndrome	0.000137	0.00371	CbGpPWpGaD
Fludrocortisone—Urticaria—Midazolam—epilepsy syndrome	0.000137	0.000948	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Carbamazepine—epilepsy syndrome	0.000136	0.000945	CcSEcCtD
Fludrocortisone—Oedema—Carbamazepine—epilepsy syndrome	0.000136	0.000945	CcSEcCtD
Fludrocortisone—Asthenia—Acetazolamide—epilepsy syndrome	0.000136	0.000943	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Zonisamide—epilepsy syndrome	0.000136	0.000942	CcSEcCtD
Fludrocortisone—Desoximetasone—NR3C1—epilepsy syndrome	0.000136	0.0311	CrCbGaD
Fludrocortisone—Infection—Carbamazepine—epilepsy syndrome	0.000136	0.000939	CcSEcCtD
Fludrocortisone—Insomnia—Zonisamide—epilepsy syndrome	0.000135	0.000936	CcSEcCtD
Fludrocortisone—Loteprednol—NR3C1—epilepsy syndrome	0.000134	0.0307	CrCbGaD
Fludrocortisone—Haemoglobin—Pregabalin—epilepsy syndrome	0.000134	0.000928	CcSEcCtD
Fludrocortisone—Haemorrhage—Pregabalin—epilepsy syndrome	0.000133	0.000924	CcSEcCtD
Fludrocortisone—Headache—Clobazam—epilepsy syndrome	0.000133	0.000923	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Carbamazepine—epilepsy syndrome	0.000132	0.000914	CcSEcCtD
Fludrocortisone—Oedema—Lamotrigine—epilepsy syndrome	0.000132	0.000914	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—VDR—epilepsy syndrome	0.000132	0.00357	CbGpPWpGaD
Fludrocortisone—Muscular weakness—Topiramate—epilepsy syndrome	0.000131	0.000909	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Clonazepam—epilepsy syndrome	0.000131	0.000908	CcSEcCtD
Fludrocortisone—Infection—Lamotrigine—epilepsy syndrome	0.000131	0.000908	CcSEcCtD
Fludrocortisone—Urticaria—Fosphenytoin—epilepsy syndrome	0.00013	0.000904	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—CDC42—epilepsy syndrome	0.00013	0.00354	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Phenytoin—epilepsy syndrome	0.00013	0.000902	CcSEcCtD
Fludrocortisone—Insomnia—Clonazepam—epilepsy syndrome	0.00013	0.000902	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Oxcarbazepine—epilepsy syndrome	0.00013	0.000897	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CHRNB2—epilepsy syndrome	0.00013	0.00351	CbGpPWpGaD
Fludrocortisone—Abdominal distension—Topiramate—epilepsy syndrome	0.000129	0.000896	CcSEcCtD
Fludrocortisone—Insomnia—Phenytoin—epilepsy syndrome	0.000129	0.000896	CcSEcCtD
Fludrocortisone—NR3C1—Circadian Clock—MEF2C—epilepsy syndrome	0.000129	0.00349	CbGpPWpGaD
Fludrocortisone—Insomnia—Oxcarbazepine—epilepsy syndrome	0.000129	0.000891	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Lamotrigine—epilepsy syndrome	0.000127	0.000883	CcSEcCtD
Fludrocortisone—Urticaria—Vigabatrin—epilepsy syndrome	0.000127	0.000881	CcSEcCtD
Fludrocortisone—Hypersensitivity—Midazolam—epilepsy syndrome	0.000127	0.00088	CcSEcCtD
Fludrocortisone—Asthenia—Propofol—epilepsy syndrome	0.000126	0.000876	CcSEcCtD
Fludrocortisone—Pancreatitis—Topiramate—epilepsy syndrome	0.000126	0.000873	CcSEcCtD
Fludrocortisone—AR—Nongenotropic Androgen signaling—SRC—epilepsy syndrome	0.000126	0.00341	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000125	0.000869	CcSEcCtD
Fludrocortisone—Urticaria—Diazepam—epilepsy syndrome	0.000125	0.000867	CcSEcCtD
Fludrocortisone—Sweating increased—Topiramate—epilepsy syndrome	0.000125	0.000867	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—MEF2C—epilepsy syndrome	0.000125	0.00338	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Carbamazepine—epilepsy syndrome	0.000124	0.000861	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—SIRT1—epilepsy syndrome	0.000124	0.00336	CbGpPWpGaD
Fludrocortisone—Hydrocortisone—SLCO1A2—epilepsy syndrome	0.000124	0.0283	CrCbGaD
Fludrocortisone—Asthenia—Midazolam—epilepsy syndrome	0.000124	0.000857	CcSEcCtD
Fludrocortisone—Insomnia—Carbamazepine—epilepsy syndrome	0.000123	0.000855	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—QARS—epilepsy syndrome	0.000123	0.00333	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—EIF2AK2—epilepsy syndrome	0.000123	0.00333	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—JUND—epilepsy syndrome	0.000123	0.00333	CbGpPWpGaD
Fludrocortisone—Haemorrhage—Gabapentin—epilepsy syndrome	0.000122	0.000847	CcSEcCtD
Fludrocortisone—Asthenia—Levetiracetam—epilepsy syndrome	0.000122	0.000846	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—YWHAZ—epilepsy syndrome	0.000122	0.0033	CbGpPWpGaD
Fludrocortisone—Urticaria—Felbamate—epilepsy syndrome	0.000121	0.00084	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Lamotrigine—epilepsy syndrome	0.00012	0.000832	CcSEcCtD
Fludrocortisone—Insomnia—Lamotrigine—epilepsy syndrome	0.000119	0.000826	CcSEcCtD
Fludrocortisone—Flurandrenolide—NR3C1—epilepsy syndrome	0.000119	0.0272	CrCbGaD
Fludrocortisone—Headache—Acetazolamide—epilepsy syndrome	0.000119	0.000823	CcSEcCtD
Fludrocortisone—Urticaria—Zonisamide—epilepsy syndrome	0.000119	0.000822	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—epilepsy syndrome	0.000118	0.00321	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000118	0.000817	CcSEcCtD
Fludrocortisone—Asthenia—Fosphenytoin—epilepsy syndrome	0.000118	0.000816	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CHRNA4—epilepsy syndrome	0.000118	0.00319	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—AQP4—epilepsy syndrome	0.000116	0.00316	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—SLC1A3—epilepsy syndrome	0.000116	0.00316	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Diazepam—epilepsy syndrome	0.000116	0.000804	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Topiramate—epilepsy syndrome	0.000116	0.000803	CcSEcCtD
Fludrocortisone—Vertigo—Valproic Acid—epilepsy syndrome	0.000115	0.000799	CcSEcCtD
Fludrocortisone—Hydrocortamate—NR3C1—epilepsy syndrome	0.000115	0.0263	CrCbGaD
Fludrocortisone—Asthenia—Vigabatrin—epilepsy syndrome	0.000115	0.000796	CcSEcCtD
Fludrocortisone—Urticaria—Clonazepam—epilepsy syndrome	0.000114	0.000792	CcSEcCtD
Fludrocortisone—Urticaria—Phenytoin—epilepsy syndrome	0.000114	0.000787	CcSEcCtD
Fludrocortisone—Cortisone acetate—NR3C1—epilepsy syndrome	0.000113	0.0259	CrCbGaD
Fludrocortisone—Asthenia—Diazepam—epilepsy syndrome	0.000113	0.000783	CcSEcCtD
Fludrocortisone—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000113	0.000783	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—TSC1—epilepsy syndrome	0.000112	0.00304	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CASP8—epilepsy syndrome	0.000111	0.00301	CbGpPWpGaD
Fludrocortisone—Hypertension—Valproic Acid—epilepsy syndrome	0.000111	0.000768	CcSEcCtD
Fludrocortisone—Headache—Propofol—epilepsy syndrome	0.00011	0.000764	CcSEcCtD
Fludrocortisone—Hypersensitivity—Zonisamide—epilepsy syndrome	0.00011	0.000762	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—BMP4—epilepsy syndrome	0.00011	0.00298	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CHRM2—epilepsy syndrome	0.000109	0.00297	CbGpPWpGaD
Fludrocortisone—Asthenia—Felbamate—epilepsy syndrome	0.000109	0.000758	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—SLC6A4—epilepsy syndrome	0.000109	0.00296	CbGpPWpGaD
Fludrocortisone—Myalgia—Valproic Acid—epilepsy syndrome	0.000109	0.000757	CcSEcCtD
Fludrocortisone—Megestrol acetate—NR3C1—epilepsy syndrome	0.000109	0.025	CrCbGaD
Fludrocortisone—Urticaria—Carbamazepine—epilepsy syndrome	0.000108	0.000751	CcSEcCtD
Fludrocortisone—Headache—Midazolam—epilepsy syndrome	0.000108	0.000748	CcSEcCtD
Fludrocortisone—Asthenia—Zonisamide—epilepsy syndrome	0.000107	0.000742	CcSEcCtD
Fludrocortisone—Amcinonide—NR3C1—epilepsy syndrome	0.000107	0.0244	CrCbGaD
Fludrocortisone—Headache—Levetiracetam—epilepsy syndrome	0.000107	0.000739	CcSEcCtD
Fludrocortisone—Erythema—Gabapentin—epilepsy syndrome	0.000106	0.000737	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—NTRK2—epilepsy syndrome	0.000106	0.00288	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—SST—epilepsy syndrome	0.000106	0.00288	CbGpPWpGaD
Fludrocortisone—AR—FOXA1 transcription factor network—JUN—epilepsy syndrome	0.000106	0.00287	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000106	0.000735	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL1RN—epilepsy syndrome	0.000106	0.00287	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000105	0.00073	CcSEcCtD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—TNF—epilepsy syndrome	0.000105	0.00284	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000105	0.000726	CcSEcCtD
Fludrocortisone—Oedema—Valproic Acid—epilepsy syndrome	0.000105	0.000726	CcSEcCtD
Fludrocortisone—Urticaria—Lamotrigine—epilepsy syndrome	0.000105	0.000726	CcSEcCtD
Fludrocortisone—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000105	0.000726	CcSEcCtD
Fludrocortisone—Vertigo—Pregabalin—epilepsy syndrome	0.000104	0.000723	CcSEcCtD
Fludrocortisone—Infection—Valproic Acid—epilepsy syndrome	0.000104	0.000721	CcSEcCtD
Fludrocortisone—Haemoglobin—Topiramate—epilepsy syndrome	0.000103	0.000716	CcSEcCtD
Fludrocortisone—Asthenia—Clonazepam—epilepsy syndrome	0.000103	0.000715	CcSEcCtD
Fludrocortisone—Headache—Fosphenytoin—epilepsy syndrome	0.000103	0.000713	CcSEcCtD
Fludrocortisone—Haemorrhage—Topiramate—epilepsy syndrome	0.000103	0.000713	CcSEcCtD
Fludrocortisone—Asthenia—Phenytoin—epilepsy syndrome	0.000103	0.000711	CcSEcCtD
Fludrocortisone—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000102	0.000707	CcSEcCtD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—epilepsy syndrome	0.000102	0.00276	CbGpPWpGaD
Fludrocortisone—Mometasone—NR3C1—epilepsy syndrome	0.000102	0.0233	CrCbGaD
Fludrocortisone—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000101	0.000702	CcSEcCtD
Fludrocortisone—Convulsion—Pregabalin—epilepsy syndrome	0.000101	0.000697	CcSEcCtD
Fludrocortisone—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000101	0.000696	CcSEcCtD
Fludrocortisone—Headache—Vigabatrin—epilepsy syndrome	0.0001	0.000695	CcSEcCtD
Fludrocortisone—Hypertension—Pregabalin—epilepsy syndrome	0.0001	0.000694	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—epilepsy syndrome	9.98e-05	0.00271	CbGpPWpGaD
Fludrocortisone—Myalgia—Pregabalin—epilepsy syndrome	9.88e-05	0.000685	CcSEcCtD
Fludrocortisone—Headache—Diazepam—epilepsy syndrome	9.87e-05	0.000684	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CHRNB2—epilepsy syndrome	9.83e-05	0.00266	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—EIF2B5—epilepsy syndrome	9.81e-05	0.00266	CbGpPWpGaD
Fludrocortisone—Asthenia—Carbamazepine—epilepsy syndrome	9.79e-05	0.000678	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—TH—epilepsy syndrome	9.74e-05	0.00264	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Lamotrigine—epilepsy syndrome	9.71e-05	0.000673	CcSEcCtD
Fludrocortisone—Vertigo—Gabapentin—epilepsy syndrome	9.56e-05	0.000663	CcSEcCtD
Fludrocortisone—Headache—Felbamate—epilepsy syndrome	9.55e-05	0.000662	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	9.55e-05	0.000661	CcSEcCtD
Fludrocortisone—Testosterone—SLCO1A2—epilepsy syndrome	9.52e-05	0.0218	CrCbGaD
Fludrocortisone—Insomnia—Valproic Acid—epilepsy syndrome	9.48e-05	0.000657	CcSEcCtD
Fludrocortisone—Oedema—Pregabalin—epilepsy syndrome	9.47e-05	0.000656	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Pregabalin—epilepsy syndrome	9.47e-05	0.000656	CcSEcCtD
Fludrocortisone—Asthenia—Lamotrigine—epilepsy syndrome	9.46e-05	0.000655	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MEF2C—epilepsy syndrome	9.45e-05	0.00256	CbGpPWpGaD
Fludrocortisone—Infection—Pregabalin—epilepsy syndrome	9.41e-05	0.000652	CcSEcCtD
Fludrocortisone—Headache—Zonisamide—epilepsy syndrome	9.35e-05	0.000648	CcSEcCtD
Fludrocortisone—Convulsion—Gabapentin—epilepsy syndrome	9.22e-05	0.000639	CcSEcCtD
Fludrocortisone—Fluocinolone Acetonide—NR3C1—epilepsy syndrome	9.22e-05	0.0211	CrCbGaD
Fludrocortisone—Dexamethasone—SLCO1A2—epilepsy syndrome	9.21e-05	0.0211	CrCbGaD
Fludrocortisone—Hypertension—Gabapentin—epilepsy syndrome	9.19e-05	0.000637	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—AGT—epilepsy syndrome	9.17e-05	0.00249	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Pregabalin—epilepsy syndrome	9.16e-05	0.000634	CcSEcCtD
Fludrocortisone—AR—Regulation of Androgen receptor activity—JUN—epilepsy syndrome	9.14e-05	0.00248	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—PLAU—epilepsy syndrome	9.11e-05	0.00247	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—FOS—epilepsy syndrome	9.06e-05	0.00246	CbGpPWpGaD
Fludrocortisone—Myalgia—Gabapentin—epilepsy syndrome	9.06e-05	0.000628	CcSEcCtD
Fludrocortisone—Headache—Clonazepam—epilepsy syndrome	9.01e-05	0.000625	CcSEcCtD
Fludrocortisone—Clobetasol propionate—NR3C1—epilepsy syndrome	8.98e-05	0.0205	CrCbGaD
Fludrocortisone—Headache—Phenytoin—epilepsy syndrome	8.95e-05	0.00062	CcSEcCtD
Fludrocortisone—Erythema—Topiramate—epilepsy syndrome	8.95e-05	0.00062	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—JUNB—epilepsy syndrome	8.94e-05	0.00242	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CHRNA4—epilepsy syndrome	8.92e-05	0.00242	CbGpPWpGaD
Fludrocortisone—Headache—Oxcarbazepine—epilepsy syndrome	8.91e-05	0.000617	CcSEcCtD
Fludrocortisone—Spironolactone—ABCC2—epilepsy syndrome	8.9e-05	0.0203	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—TFAM—epilepsy syndrome	8.88e-05	0.00241	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Gabapentin—epilepsy syndrome	8.69e-05	0.000602	CcSEcCtD
Fludrocortisone—Oedema—Gabapentin—epilepsy syndrome	8.69e-05	0.000602	CcSEcCtD
Fludrocortisone—Triamcinolone—BCHE—epilepsy syndrome	8.68e-05	0.0199	CrCbGaD
Fludrocortisone—Fluorometholone—NR3C1—epilepsy syndrome	8.65e-05	0.0198	CrCbGaD
Fludrocortisone—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	8.63e-05	0.000598	CcSEcCtD
Fludrocortisone—Infection—Gabapentin—epilepsy syndrome	8.63e-05	0.000598	CcSEcCtD
Fludrocortisone—Insomnia—Pregabalin—epilepsy syndrome	8.57e-05	0.000594	CcSEcCtD
Fludrocortisone—Headache—Carbamazepine—epilepsy syndrome	8.55e-05	0.000592	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CDC42—epilepsy syndrome	8.55e-05	0.00232	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Gabapentin—epilepsy syndrome	8.4e-05	0.000582	CcSEcCtD
Fludrocortisone—Methylprednisolone—NR3C1—epilepsy syndrome	8.36e-05	0.0191	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—JUNB—epilepsy syndrome	8.35e-05	0.00226	CbGpPWpGaD
Fludrocortisone—Urticaria—Valproic Acid—epilepsy syndrome	8.32e-05	0.000577	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—SLC6A4—epilepsy syndrome	8.29e-05	0.00225	CbGpPWpGaD
Fludrocortisone—Testosterone—CYP11A1—epilepsy syndrome	8.29e-05	0.0189	CrCbGaD
Fludrocortisone—Headache—Lamotrigine—epilepsy syndrome	8.26e-05	0.000572	CcSEcCtD
Fludrocortisone—AR—Regulation of Androgen receptor activity—SRC—epilepsy syndrome	8.2e-05	0.00222	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—SIRT1—epilepsy syndrome	8.11e-05	0.0022	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—NTRK2—epilepsy syndrome	8.07e-05	0.00219	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—SST—epilepsy syndrome	8.07e-05	0.00219	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—AVP—epilepsy syndrome	8.06e-05	0.00219	CbGpPWpGaD
Fludrocortisone—Vertigo—Topiramate—epilepsy syndrome	8.04e-05	0.000557	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL1RN—epilepsy syndrome	8.03e-05	0.00218	CbGpPWpGaD
Fludrocortisone—Dexamethasone—CYP11A1—epilepsy syndrome	8.02e-05	0.0183	CrCbGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—BDNF—epilepsy syndrome	7.94e-05	0.00215	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	7.91e-05	0.000548	CcSEcCtD
Fludrocortisone—Insomnia—Gabapentin—epilepsy syndrome	7.86e-05	0.000544	CcSEcCtD
Fludrocortisone—AR—Nongenotropic Androgen signaling—AKT1—epilepsy syndrome	7.82e-05	0.00212	CbGpPWpGaD
Fludrocortisone—Convulsion—Topiramate—epilepsy syndrome	7.76e-05	0.000538	CcSEcCtD
Fludrocortisone—Hypertension—Topiramate—epilepsy syndrome	7.73e-05	0.000536	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—FOS—epilepsy syndrome	7.73e-05	0.0021	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Valproic Acid—epilepsy syndrome	7.72e-05	0.000535	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—SNRPE—epilepsy syndrome	7.66e-05	0.00208	CbGpPWpGaD
Fludrocortisone—Myalgia—Topiramate—epilepsy syndrome	7.62e-05	0.000528	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—HES1—epilepsy syndrome	7.62e-05	0.00207	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CCL2—epilepsy syndrome	7.55e-05	0.00205	CbGpPWpGaD
Fludrocortisone—Urticaria—Pregabalin—epilepsy syndrome	7.52e-05	0.000521	CcSEcCtD
Fludrocortisone—Asthenia—Valproic Acid—epilepsy syndrome	7.52e-05	0.000521	CcSEcCtD
Fludrocortisone—AR—Gene Expression—WARS—epilepsy syndrome	7.52e-05	0.00204	CbGpPWpGaD
Fludrocortisone—Fluoxymesterone—NR3C1—epilepsy syndrome	7.41e-05	0.0169	CrCbGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—TH—epilepsy syndrome	7.39e-05	0.002	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—MEF2C—epilepsy syndrome	7.37e-05	0.002	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—SOCS3—epilepsy syndrome	7.33e-05	0.00199	CbGpPWpGaD
Fludrocortisone—Oedema—Topiramate—epilepsy syndrome	7.31e-05	0.000506	CcSEcCtD
Fludrocortisone—Infection—Topiramate—epilepsy syndrome	7.26e-05	0.000503	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—YWHAZ—epilepsy syndrome	7.13e-05	0.00193	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—VDR—epilepsy syndrome	7.09e-05	0.00192	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Topiramate—epilepsy syndrome	7.06e-05	0.000489	CcSEcCtD
Fludrocortisone—Triamcinolone—NR3C1—epilepsy syndrome	7.05e-05	0.0161	CrCbGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—NGF—epilepsy syndrome	7.05e-05	0.00191	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—NR3C1—epilepsy syndrome	7.01e-05	0.0019	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Pregabalin—epilepsy syndrome	6.98e-05	0.000484	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—JUN—epilepsy syndrome	6.93e-05	0.00188	CbGpPWpGaD
Fludrocortisone—Urticaria—Gabapentin—epilepsy syndrome	6.9e-05	0.000478	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—RELA—epilepsy syndrome	6.89e-05	0.00187	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—epilepsy syndrome	6.88e-05	0.00186	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—FOS—epilepsy syndrome	6.81e-05	0.00185	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—POMC—epilepsy syndrome	6.8e-05	0.00184	CbGpPWpGaD
Fludrocortisone—Asthenia—Pregabalin—epilepsy syndrome	6.8e-05	0.000471	CcSEcCtD
Fludrocortisone—Spironolactone—NR3C1—epilepsy syndrome	6.79e-05	0.0155	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—BDNF—epilepsy syndrome	6.75e-05	0.00183	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—SIRT1—epilepsy syndrome	6.72e-05	0.00182	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—HTR2A—epilepsy syndrome	6.71e-05	0.00182	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	6.66e-05	0.000461	CcSEcCtD
Fludrocortisone—Dexamethasone—NOS2—epilepsy syndrome	6.64e-05	0.0152	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ABCB1—epilepsy syndrome	6.64e-05	0.0018	CbGpPWpGaD
Fludrocortisone—Insomnia—Topiramate—epilepsy syndrome	6.61e-05	0.000458	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—epilepsy syndrome	6.57e-05	0.00178	CbGpPWpGaD
Fludrocortisone—Headache—Valproic Acid—epilepsy syndrome	6.56e-05	0.000455	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—TSC2—epilepsy syndrome	6.54e-05	0.00177	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—JUN—epilepsy syndrome	6.51e-05	0.00176	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—MEF2C—epilepsy syndrome	6.47e-05	0.00175	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Gabapentin—epilepsy syndrome	6.4e-05	0.000443	CcSEcCtD
Fludrocortisone—Prednisone—NR3C1—epilepsy syndrome	6.4e-05	0.0146	CrCbGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—epilepsy syndrome	6.39e-05	0.00173	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—NR3C1—epilepsy syndrome	6.38e-05	0.00173	CbGpPWpGaD
Fludrocortisone—Medroxyprogesterone Acetate—NR3C1—epilepsy syndrome	6.36e-05	0.0145	CrCbGaD
Fludrocortisone—Asthenia—Gabapentin—epilepsy syndrome	6.23e-05	0.000432	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—SRC—epilepsy syndrome	6.22e-05	0.00169	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—ATM—epilepsy syndrome	6.16e-05	0.00167	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—AVP—epilepsy syndrome	6.12e-05	0.00166	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—JUN—epilepsy syndrome	6.04e-05	0.00164	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—BDNF—epilepsy syndrome	6.02e-05	0.00163	CbGpPWpGaD
Fludrocortisone—Headache—Pregabalin—epilepsy syndrome	5.93e-05	0.000411	CcSEcCtD
Fludrocortisone—Prednisolone—NR3C1—epilepsy syndrome	5.89e-05	0.0135	CrCbGaD
Fludrocortisone—Prednisone—CYP2C19—epilepsy syndrome	5.83e-05	0.0133	CrCbGaD
Fludrocortisone—Urticaria—Topiramate—epilepsy syndrome	5.8e-05	0.000402	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—HES1—epilepsy syndrome	5.78e-05	0.00157	CbGpPWpGaD
Fludrocortisone—Betamethasone—NR3C1—epilepsy syndrome	5.78e-05	0.0132	CrCbGaD
Fludrocortisone—NR3C1—Gene Expression—WARS—epilepsy syndrome	5.7e-05	0.00155	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—QARS—epilepsy syndrome	5.7e-05	0.00154	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—MEF2C—epilepsy syndrome	5.59e-05	0.00152	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—AGT—epilepsy syndrome	5.59e-05	0.00151	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—RELA—epilepsy syndrome	5.58e-05	0.00151	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—JUN—epilepsy syndrome	5.55e-05	0.0015	CbGpPWpGaD
Fludrocortisone—Headache—Gabapentin—epilepsy syndrome	5.44e-05	0.000377	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—SRC—epilepsy syndrome	5.41e-05	0.00147	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—YWHAZ—epilepsy syndrome	5.41e-05	0.00147	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MMP9—epilepsy syndrome	5.4e-05	0.00146	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Topiramate—epilepsy syndrome	5.38e-05	0.000373	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CASP8—epilepsy syndrome	5.38e-05	0.00146	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—NGF—epilepsy syndrome	5.34e-05	0.00145	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—EIF2S1—epilepsy syndrome	5.34e-05	0.00145	CbGpPWpGaD
Fludrocortisone—Megestrol acetate—ABCB1—epilepsy syndrome	5.27e-05	0.012	CrCbGaD
Fludrocortisone—Asthenia—Topiramate—epilepsy syndrome	5.24e-05	0.000363	CcSEcCtD
Fludrocortisone—Hydrocortisone—ABCG2—epilepsy syndrome	5.23e-05	0.0119	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—HSPB1—epilepsy syndrome	5.16e-05	0.0014	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—IL6ST—epilepsy syndrome	5.14e-05	0.00139	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	5.11e-05	0.00138	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—HTR2A—epilepsy syndrome	5.09e-05	0.00138	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—epilepsy syndrome	4.94e-05	0.00134	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—JUN—epilepsy syndrome	4.89e-05	0.00133	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—BCL2—epilepsy syndrome	4.62e-05	0.00125	CbGpPWpGaD
Fludrocortisone—Headache—Topiramate—epilepsy syndrome	4.58e-05	0.000317	CcSEcCtD
Fludrocortisone—AR—Gene Expression—EIF2B5—epilepsy syndrome	4.55e-05	0.00123	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—AKT1—epilepsy syndrome	4.55e-05	0.00123	CbGpPWpGaD
Fludrocortisone—Hydrocortisone—NR3C1—epilepsy syndrome	4.51e-05	0.0103	CrCbGaD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—epilepsy syndrome	4.48e-05	0.00122	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	4.46e-05	0.00121	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MTOR—epilepsy syndrome	4.43e-05	0.0012	CbGpPWpGaD
Fludrocortisone—Dexamethasone—ABCC2—epilepsy syndrome	4.41e-05	0.0101	CrCbGaD
Fludrocortisone—NR3C1—Gene Expression—QARS—epilepsy syndrome	4.32e-05	0.00117	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—JUNB—epilepsy syndrome	4.3e-05	0.00117	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—JUNB—epilepsy syndrome	4.15e-05	0.00112	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—TFAM—epilepsy syndrome	4.12e-05	0.00112	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CASP3—epilepsy syndrome	4.07e-05	0.0011	CbGpPWpGaD
Fludrocortisone—Methylprednisolone—ABCB1—epilepsy syndrome	4.04e-05	0.00922	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	4.03e-05	0.00109	CbGpPWpGaD
Fludrocortisone—Testosterone—ABCG2—epilepsy syndrome	4.03e-05	0.0092	CrCbGaD
Fludrocortisone—Triamcinolone—PTGS2—epilepsy syndrome	4e-05	0.00915	CrCbGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	3.97e-05	0.00108	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	3.97e-05	0.00108	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—JUN—epilepsy syndrome	3.95e-05	0.00107	CbGpPWpGaD
Fludrocortisone—Dexamethasone—ABCG2—epilepsy syndrome	3.89e-05	0.0089	CrCbGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	3.85e-05	0.00104	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	3.83e-05	0.00104	CbGpPWpGaD
Fludrocortisone—Progesterone—NR3C1—epilepsy syndrome	3.67e-05	0.0084	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	3.63e-05	0.000985	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—epilepsy syndrome	3.63e-05	0.000983	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—SNRPE—epilepsy syndrome	3.55e-05	0.000964	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—SIRT1—epilepsy syndrome	3.47e-05	0.000939	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—EIF2B5—epilepsy syndrome	3.45e-05	0.000937	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—VEGFA—epilepsy syndrome	3.45e-05	0.000936	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—VDR—epilepsy syndrome	3.41e-05	0.000926	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	3.37e-05	0.000914	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	3.37e-05	0.000912	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—AKT1—epilepsy syndrome	3.36e-05	0.000912	CbGpPWpGaD
Fludrocortisone—Dexamethasone—NR3C1—epilepsy syndrome	3.36e-05	0.00768	CrCbGaD
Fludrocortisone—Progesterone—CYP2C19—epilepsy syndrome	3.35e-05	0.00765	CrCbGaD
Fludrocortisone—AR—Generic Transcription Pathway—VDR—epilepsy syndrome	3.29e-05	0.000892	CbGpPWpGaD
Fludrocortisone—Betamethasone—PTGS2—epilepsy syndrome	3.28e-05	0.00749	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	3.28e-05	0.000888	CbGpPWpGaD
Fludrocortisone—Spironolactone—ABCB1—epilepsy syndrome	3.28e-05	0.00749	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—H2AFX—epilepsy syndrome	3.24e-05	0.000878	CbGpPWpGaD
Fludrocortisone—Prednisone—ALB—epilepsy syndrome	3.23e-05	0.00739	CrCbGaD
Fludrocortisone—Testosterone—CYP2C19—epilepsy syndrome	3.16e-05	0.00723	CrCbGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—JUNB—epilepsy syndrome	3.15e-05	0.000853	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—TFAM—epilepsy syndrome	3.12e-05	0.000847	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—YWHAZ—epilepsy syndrome	3.12e-05	0.000847	CbGpPWpGaD
Fludrocortisone—Prednisone—ABCB1—epilepsy syndrome	3.09e-05	0.00705	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—NR3C1—epilepsy syndrome	3.07e-05	0.000833	CbGpPWpGaD
Fludrocortisone—Dexamethasone—CYP2C19—epilepsy syndrome	3.06e-05	0.007	CrCbGaD
Fludrocortisone—Methyltestosterone—ALB—epilepsy syndrome	3.03e-05	0.00692	CrCbGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	3.02e-05	0.000818	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	3.01e-05	0.000816	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NR3C1—epilepsy syndrome	2.96e-05	0.000803	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	2.94e-05	0.000797	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	2.92e-05	0.000792	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	2.88e-05	0.000782	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	2.86e-05	0.000776	CbGpPWpGaD
Fludrocortisone—Prednisolone—ABCB1—epilepsy syndrome	2.84e-05	0.0065	CrCbGaD
Fludrocortisone—Betamethasone—ABCB1—epilepsy syndrome	2.79e-05	0.00637	CrCbGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—epilepsy syndrome	2.75e-05	0.000746	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—epilepsy syndrome	2.73e-05	0.000739	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—SNRPE—epilepsy syndrome	2.7e-05	0.000731	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	2.55e-05	0.000692	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—TNF—epilepsy syndrome	2.53e-05	0.000686	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—VDR—epilepsy syndrome	2.5e-05	0.000677	CbGpPWpGaD
Fludrocortisone—Progesterone—CYP2D6—epilepsy syndrome	2.48e-05	0.00567	CrCbGaD
Fludrocortisone—AR—Gene Expression—EIF2S1—epilepsy syndrome	2.48e-05	0.000672	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	2.45e-05	0.000665	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—HSPB1—epilepsy syndrome	2.39e-05	0.000649	CbGpPWpGaD
Fludrocortisone—Dexamethasone—CYP2D6—epilepsy syndrome	2.27e-05	0.00519	CrCbGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—AKT1—epilepsy syndrome	2.2e-05	0.000598	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	2.19e-05	0.000593	CbGpPWpGaD
Fludrocortisone—Hydrocortisone—ABCB1—epilepsy syndrome	2.18e-05	0.00497	CrCbGaD
Fludrocortisone—AR—Gene Expression—JUNB—epilepsy syndrome	2e-05	0.000541	CbGpPWpGaD
Fludrocortisone—Dexamethasone—PTGS2—epilepsy syndrome	1.91e-05	0.00436	CrCbGaD
Fludrocortisone—NR3C1—Gene Expression—EIF2S1—epilepsy syndrome	1.88e-05	0.00051	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.83e-05	0.000495	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—HSPB1—epilepsy syndrome	1.81e-05	0.000492	CbGpPWpGaD
Fludrocortisone—Progesterone—ABCB1—epilepsy syndrome	1.77e-05	0.00405	CrCbGaD
Fludrocortisone—Testosterone—ALB—epilepsy syndrome	1.76e-05	0.00401	CrCbGaD
Fludrocortisone—Testosterone—ABCB1—epilepsy syndrome	1.68e-05	0.00383	CrCbGaD
Fludrocortisone—Dexamethasone—ABCB1—epilepsy syndrome	1.62e-05	0.00371	CrCbGaD
Fludrocortisone—AR—Gene Expression—SIRT1—epilepsy syndrome	1.61e-05	0.000436	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—VDR—epilepsy syndrome	1.58e-05	0.00043	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—JUNB—epilepsy syndrome	1.51e-05	0.000411	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—H2AFX—epilepsy syndrome	1.5e-05	0.000407	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—YWHAZ—epilepsy syndrome	1.45e-05	0.000393	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NR3C1—epilepsy syndrome	1.43e-05	0.000387	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—SIRT1—epilepsy syndrome	1.22e-05	0.000331	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—VDR—epilepsy syndrome	1.2e-05	0.000326	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—H2AFX—epilepsy syndrome	1.14e-05	0.000309	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—YWHAZ—epilepsy syndrome	1.1e-05	0.000298	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—AKT1—epilepsy syndrome	9.41e-06	0.000255	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—AKT1—epilepsy syndrome	4.37e-06	0.000118	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—AKT1—epilepsy syndrome	3.31e-06	8.98e-05	CbGpPWpGaD
